The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours
Subscribe To Our Newsletter & Stay Updated